BF
JAZZ icon

BOK Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

BOK Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,541
Closed -$960K – 999
2021
Q4 		$960K Sell
7,541
-304
-4% -$40K 0.01% 589
2021
Q3 		$1.02M Buy
+7,845
New +$1.19M 0.02% 562
2021
Q1 		$1.01M Sell
6,165
-284
-4% -$46.7K 0.02% 547
2020
Q4 		$1.06M Buy
6,449
+1,483
+30% +$221K 0.02% 503
2020
Q3 		$708K Buy
4,966
+224
+5% +$27.8K 0.02% 540
2020
Q2 		$524K Sell
4,742
-1,041
-18% -$115K 0.01% 615
2020
Q1 		$577K Buy
5,783
+2,555
+79% +$330K 0.02% 546
2019
Q4 		$482K Buy
+3,228
New +$439K 0.01% 706

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

BOK Financial's JAZZ Position: Q1 2022 in Review

BOK Financial sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2022, closing a stake of 7,541 shares — an estimated $960K sold.

BOK Financial first reported a position in JAZZ in Q4 2019 and held it in 8 quarters. The position peaked at $1.06M in Q4 2020. 462 funds tracked by Wall St. Rank hold JAZZ as of Q1 2022.

  • BOK Financial reported no remaining Jazz Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • BOK Financial sold 7,541 Jazz Pharmaceuticals shares in Q1 2022, an estimated $960K.
  • BOK Financial first reported a position in Jazz Pharmaceuticals in Q4 2019 and held it in 8 quarters.
  • BOK Financial's Jazz Pharmaceuticals position peaked at $1.06M in Q4 2020.
  • 462 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2022.

Based on BOK Financial's 13F filing for Q1 2022, filed 13 May 2022.